Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Shares Up 1.8% – What’s Next?

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) shares rose 1.8% on Friday . The stock traded as high as $33.72 and last traded at $33.72. 16,550 shares traded hands during mid-day trading, a decline of 42% from the average daily volume of 28,454 shares. The stock had previously closed at $33.11.

Invesco Nasdaq Biotechnology ETF Trading Up 1.8%

The company has a 50 day moving average price of $31.65 and a 200 day moving average price of $30.12. The company has a market capitalization of $78.90 million, a price-to-earnings ratio of 17.03 and a beta of 0.60.

Invesco Nasdaq Biotechnology ETF Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, June 26th. Investors of record on Monday, June 22nd were issued a $0.0342 dividend. The ex-dividend date was Monday, June 22nd. This represents a $0.14 annualized dividend and a yield of 0.4%.

Institutional Trading of Invesco Nasdaq Biotechnology ETF

Several institutional investors and hedge funds have recently added to or reduced their stakes in IBBQ. Osaic Holdings Inc. lifted its stake in shares of Invesco Nasdaq Biotechnology ETF by 28.4% in the 2nd quarter. Osaic Holdings Inc. now owns 4,757 shares of the company’s stock valued at $101,000 after purchasing an additional 1,052 shares during the period. Ascentis Independent Advisors acquired a new stake in shares of Invesco Nasdaq Biotechnology ETF during the first quarter worth $31,000. Royal Bank of Canada acquired a new stake in shares of Invesco Nasdaq Biotechnology ETF during the fourth quarter worth $37,000. International Assets Investment Management LLC bought a new stake in Invesco Nasdaq Biotechnology ETF in the fourth quarter valued at about $41,000. Finally, Advisory Services Network LLC bought a new stake in Invesco Nasdaq Biotechnology ETF in the third quarter valued at about $52,000.

About Invesco Nasdaq Biotechnology ETF

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.